ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6423
0.06%
Brent Oil
76.175
-0.43%
Bitcoin
99,247.93
0.96%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Santhera Pharmaceuticals Holding Ag (0QN1) Cotización

Santhera Pharmaceuticals Holding Ag

Santhera Pharmaceuticals Holding Ag (0QN1)

LSE
190.20
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
190.20
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
4,661
0.00 Rango del Día 0.00
190.20 Rango de 52 semanas 190.20
Capitalización de Mercado [m]
2.152B
Precio Anterior
190.20
Precio de Apertura
-
Hora
206
@
14.68
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
496
Acciones en circulación
11,315,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
1.95
Beneficio por acción (BPA)
4.84
turnover
103.41M
Beneficio neto
54.78M

Acerca de Santhera Pharmaceuticals Holding Ag

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.santhera.com
Sede
Liestal, Che
Fundado
-
Santhera Pharmaceuticals Holding Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QN1. The last closing price for Santhera Pharmaceuticals was CHF190.20. Over the last year, Santhera Pharmaceuticals shares have traded in a share price range of CHF 190.20 to CHF 190.20.

Santhera Pharmaceuticals currently has 11,315,000 shares in issue. The market capitalisation of Santhera Pharmaceuticals is CHF2.15 billion. Santhera Pharmaceuticals has a price to earnings ratio (PE ratio) of 1.95.

0QN1 Últimas noticias

Más noticias

Santhera publiziert Zeitplan für die Aktienzusammenlegung

Santhera publiziert Zeitplan für die Aktienzusammenlegung NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...

29 Junio 2023
GlobeNewswire Inc.

Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Shareholders Approve all Board Proposals at Today’s Annual General Meeting Pratteln, Switzerland, June 27, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved...

27 Junio 2023
GlobeNewswire Inc.

Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren

Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren Ad-hoc-Mitteilung...

20 Junio 2023
GlobeNewswire Inc.

Santhera Publishes Agenda for its Annual General Meeting

Santhera Publishes Agenda for its Annual General Meeting NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...

06 Junio 2023
GlobeNewswire Inc.

Santhera veröffentlicht Jahresbericht 2022

Santhera veröffentlicht Jahresbericht 2022 Ad-hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 31. Mai 2023 – Santhera Pharmaceuticals (SIX: SANN) gibt die Veröffentlichung des...

31 Mayo 2023
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
100190.2190.2190.2831190.2DE
400190.2190.2190.21019190.2DE
1200190.2190.2190.2496190.2DE
2600190.2190.2190.2328190.2DE
5200190.2190.2190.2433190.2DE
15600190.2190.2190.21835190.2DE
26000190.2190.2190.21736190.2DE

0QN1 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Santhera Pharmaceuticals?
El precio actual de las acciones de Santhera Pharmaceuticals es CHF 190.20
¿Cuántas acciones de Santhera Pharmaceuticals están en circulación?
Santhera Pharmaceuticals tiene 11,315,000 acciones en circulación
¿Cuál es la capitalización de mercado de Santhera Pharmaceuticals?
La capitalización de mercado de Santhera Pharmaceuticals es CHF 2.15B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Santhera Pharmaceuticals?
Santhera Pharmaceuticals ha negociado en un rango de CHF 190.20 a CHF 190.20 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Santhera Pharmaceuticals?
El ratio precio/beneficio de Santhera Pharmaceuticals es 1.95
¿Cuál es el ratio de efectivo a ventas de Santhera Pharmaceuticals?
El ratio de efectivo a ventas de Santhera Pharmaceuticals es 1.03
¿Cuál es la moneda de reporte de Santhera Pharmaceuticals?
Santhera Pharmaceuticals presenta sus resultados financieros en CHF
¿Cuál es el último ingresos anual de Santhera Pharmaceuticals?
El último ingresos anual de Santhera Pharmaceuticals es CHF 103.41M
¿Cuál es el último beneficio anual de Santhera Pharmaceuticals?
El último beneficio anual de Santhera Pharmaceuticals es CHF 54.78M
¿Cuál es la dirección registrada de Santhera Pharmaceuticals?
La dirección registrada de Santhera Pharmaceuticals es HAMMERSTRASSE 49, LIESTAL, 4410
¿Cuál es la dirección del sitio web de Santhera Pharmaceuticals?
La dirección del sitio web de Santhera Pharmaceuticals es www.santhera.com
¿En qué sector industrial opera Santhera Pharmaceuticals?
Santhera Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
I ll be back I ll be back 1 minuto hace
4u, it's been a while my friend.

I remember our last BK play and how well we did on that one.

Let's hope we hit another homerun here.
MGON
XMaster2023 XMaster2023 1 minuto hace
The Shorts would like us to forget 5/10/22 as there is a mountain of evidence that points to the manipulation efforts by the market makers.
I watched the price start falling prior to any announcement or news. The market makers need to pay for their greed on that day.
NWBO
Shawonsarker84 Shawonsarker84 2 minutos hace
Get ready for round 2 of control change run! Will we hit another 52-week high .0046?

All other exchanges NASDAQ, NYC, and AMEX are all-time high, including scams except OTC exchange. I do believe that only a handful of stocks like HMBL are ready to run. Upside huge and downside low.
HMBL
zerosnoop zerosnoop 3 minutos hace
So a U.S. government-supported financial institution specializing in global trade financing is backing the PROVEN AOT as per the FACTS in the RECENT PR below.


https://www.accesswire.com/959008/qs-energy-announces-milestones-in-global-sales-activity-and-strategic-partnerships-a
QSEP
Graniteguy Graniteguy 3 minutos hace
I consider the context and content of the messaging and the known facts ie. their schtick never changes. That should be a "tell" right there unless your your gullible, predisposed to thinking the worst (sounds like you are) or suffering from cognitive dissonance. To each their own but my ability to
AVXL
glens0 glens0 4 minutos hace
$ASNS According to Yahoo Float 2.48M shares OS 3.02M shares.
https://knowthefloat.com/ticker/asns
ASNS
StayHumble StayHumble 4 minutos hace
Lots of💹HISTORIC $HIRU XPERT interest wow💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/historical
HIRU
lodas lodas 4 minutos hace
why do you avoid the question ron????..... post the signed ruling by Judge Colyer that awarded WMI 309 Billion dollars in RICO damages against JPM, and the FDIC.... I have continually asked you this question through the years, but you put me on ignore so as not to respond....Hiding behind the comput
JPM
zerosnoop zerosnoop 4 minutos hace
Oh so the debt to Temple University is going to get written off. Just what the paid bashers & naked shorters didn't want to hear before the xmas break hah hah. All the ducks are being lined up now. The SHORT SQUEEZE will be fun to watch. The PROVEN AOT is a "GAME CHANGER" for the oil industry.
QSEP
TRAPPER JIM TRAPPER JIM 5 minutos hace
Yes ma'am. He sure is. We're supposed to get between 4-10 inches of snow tonight 
zerosnoop zerosnoop 6 minutos hace
The below is so TRUE in regards to QSEP

A stock basher is someone who manipulates the market to cause a drop in asset prices.

Stock bashers disseminate misinformation in the hopes that investors will believe the false claims and sell their stock before the price drops.
QSEP
StayHumble StayHumble 6 minutos hace
Kramer NakedShorted💹4Bill+$DBMM shares4Charity?🔥💹

Source: TDA 2014 Chart https://investorshub.advfn.com/uimage/uploads/2023/1/29/cpbxb2014_dbmm_trade_data.png Source: https://fintel.io/s/us/dbmm
https://investorshub.advfn.com/uimage/uploads/2023/1/29/hn
DBMM
NeoSunTzu NeoSunTzu 6 minutos hace
It becomes EXREMELY TIRESOME to fully detail EVERY SINGLE DAMN POINT about this story which has a million data points to speak of. My point is they will HIGHLY LIKELY NOT get put back on the NYSE while under c'ship UNLESS our boys want to make an explicit point. Additionally, trading on the NYSE und
zerosnoop zerosnoop 7 minutos hace
Lets see if any of these paid bashers, naked shorters or compulsive liar's bother to show up at the shareholders meeting in February to ask any questions. Common sense tells me these uneducated fools with a low IQ, cowards, grubs & keyboard warriors will stay hiding in their basement hah hah hah
QSEP
236T568 236T568 7 minutos hace
Yikes
https://x.com/visegrad24/status/1876118192168599586?s=19
3331 3331 8 minutos hace
I have Staelin penned as a masterful business strategist. He MUST have a plan.
GetSeriousOK (11/7/23)
BIEL
Loudanepro Loudanepro 8 minutos hace
Here are some of them; I’m sure you’ll recognize some of the aliases

https://www.sec.gov/newsroom/press-releases/2022-221
TTCM
Merv77 Merv77 8 minutos hace
fFIE Looks like a short squeeze happening soon ? 
joyceschoice joyceschoice 8 minutos hace
Good point. Let's see if the mods delete this post.
LEHNQ
Merv77 Merv77 9 minutos hace
FFIR stock to look at 
marcis marcis 9 minutos hace
Dude they voted to have the 2024 fins buy the end of April

You make a bogus claim

And the SEC had it’s audit guidelines changed just on Dec15

Next
RDAR
MartinLutherKing MartinLutherKing 11 minutos hace
Do you think the CEo fitzgerald and all his nobel lab rats in management are pocketed investors money while they sabotage the cure to cancer
timberwolf7 timberwolf7 12 minutos hace
TNXP presentation dated 2 Jan 2025. Slide 45 has a 'timeline' listing...

https://d1io3yog0oux5.cloudfront.net/_d620cad351857eb785bc6984eeac7786/tonixpharma/db/211/4414/pdf/Tonix+Short+Investor+Presentation+01.02.25+v1.pdf
TNXP
nowwhat2 nowwhat2 12 minutos hace
WHY SO HARD DROP RIGHT BACK DOWN ?........

https://investorshub.advfn.com/uimage/uploads/2025/1/5/ckgzmtotal_!_5_CAPT_7pm_XRP_RESIST.jpg




https://investorshub.advfn.com/uimage/uploads/2025/1/5/ouvwitotal_!_5_3m_7pm_RESIST.jpg

Su Consulta Reciente

LSE
0QN1
Santhera Pharmaceuticals
BIT
AL1020
Banca Aletti &
ASX
SBROB
Sabre Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados